Description of Collaborative Activity: |
The I-Corps™ at NIH program is focused on educating researchers and technologists on how to translate technologies from the lab into the marketplace. The program is designed to provide three-member project teams with access to instruction and mentoring in order to accelerate the translation of technologies currently being developed with NIH and CDC SBIR and STTR funding. Through the 8.5 week program training, companies are expected to conduct 100 interviews to gather stakeholder feedback on the product. So far, more than 100 companies have gone through the program. It is anticipated that outcomes for the I-Corps™ teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies. Currently NCI is reviewing the application for the second cohort of 2022. From fiscal year 2023, the management of the program will be transferred from the NCI to NIH. |
NIH Participating Institutes/Centers/Office of the Director: |
NCATS, NCCIH, NHGRI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIMH, NINDS |
